Literature DB >> 24710614

Regional variation in the correlation of antibody and T-cell responses to Trypanosoma cruzi.

Diana L Martin1, Morgan Marks2, Gerson Galdos-Cardenas2, Robert H Gilman2, Brook Goodhew2, Lisbeth Ferrufino2, Anthony Halperin2, Gerardo Sanchez2, Manuela Verastegui2, Patricia Escalante2, Cesar Naquira2, Michael Z Levy2, Caryn Bern2.   

Abstract

Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, is a major cause of morbidity and mortality in Central and South America. Geographic variations in the sensitivity of serologic diagnostic assays to T. cruzi may reflect differences in T. cruzi exposure. We measured parasite-specific T-cell responses among seropositive individuals in two populations from South America with widely varying antibody titers against T. cruzi. Antibody titers among seropositive individuals were significantly lower in Arequipa, Peru compared with Santa Cruz, Bolivia. Similarly, the proportion of seropositive individuals with positive T-cell responses was lower in Peru than Bolivia, resulting in overall lower frequencies of interferon-γ (IFNγ)-secreting cells from Peruvian samples. However, the magnitude of the IFNγ response was similar among the IFNγ responders in both locations. These data indicate that immunological discrepancies based on geographic region are reflected in T-cell responses as well as antibody responses. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24710614      PMCID: PMC4047731          DOI: 10.4269/ajtmh.13-0391

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  33 in total

1.  Validation of a rapid and reliable test for diagnosis of chagas' disease by detection of Trypanosoma cruzi-specific antibodies in blood of donors and patients in Central America.

Authors:  Carlos Ponce; Elisa Ponce; Elizabeth Vinelli; Alberto Montoya; Vilma de Aguilar; Antonio Gonzalez; Bianca Zingales; Rafael Rangel-Aldao; Mariano J Levin; Javan Esfandiari; Eufrosina S Umezawa; Alejandro O Luquetti; José Franco da Silveira
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

2.  T cell immunity to herpes simplex viruses in seronegative subjects: silent infection or acquired immunity?

Authors:  Christine M Posavad; Anna Wald; Nancy Hosken; Meei Li Huang; David M Koelle; Rhoda L Ashley; Lawrence Corey
Journal:  J Immunol       Date:  2003-04-15       Impact factor: 5.422

3.  Exposure to hepatitis C virus induces cellular immune responses without detectable viremia or seroconversion.

Authors:  Maged Al-Sherbiny; Ahmed Osman; Nahla Mohamed; Mohamed Tarek Shata; Fatma Abdel-Aziz; Mohamed Abdel-Hamid; Sayed F Abdelwahab; Nabiel Mikhail; Sonia Stoszek; Lionello Ruggeri; Antonella Folgori; Alfredo Nicosia; Alfred M Prince; G Thomas Strickland
Journal:  Am J Trop Med Hyg       Date:  2005-07       Impact factor: 2.345

4.  Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment.

Authors:  E John Wherry; Joseph N Blattman; Kaja Murali-Krishna; Robbert van der Most; Rafi Ahmed
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

5.  Direct analysis of genetic variability in Trypanosoma cruzi populations from tissues of Colombian chagasic patients.

Authors:  German Zafra; Julio Cesar Mantilla; Jesús Jácome; Andréa Mara Macedo; Clara Isabel González
Journal:  Hum Pathol       Date:  2011-02-17       Impact factor: 3.466

6.  Trypanosoma cruzi-specific immune responses in subjects from endemic areas of Chagas disease of Argentina.

Authors:  Gabriela C Olivera; Maria C Albareda; Maria G Alvarez; Ana M De Rissio; Laura E Fichera; Gretchen Cooley; Pedro Yachelini; Hugo A Hrellac; Hilda Riboldi; Susana A Laucella; Rick L Tarleton; Miriam Postan
Journal:  Microbes Infect       Date:  2010-02-01       Impact factor: 2.700

7.  Frequency of interferon- gamma -producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease.

Authors:  Susana A Laucella; Miriam Postan; Diana Martin; Bolyn Hubby Fralish; Maria C Albareda; Maria G Alvarez; Bruno Lococo; Gustavo Barbieri; Rodolfo J Viotti; Rick L Tarleton
Journal:  J Infect Dis       Date:  2004-02-17       Impact factor: 5.226

Review 8.  Implications of genetic variability of Trypanosoma cruzi for the pathogenesis of Chagas disease.

Authors:  Fernanda da Silva Manoel-Caetano; Ana Elizabete Silva
Journal:  Cad Saude Publica       Date:  2007-10       Impact factor: 1.632

Review 9.  A systematic review of high quality diagnostic tests for Chagas disease.

Authors:  Anna M Afonso; Mark H Ebell; Rick L Tarleton
Journal:  PLoS Negl Trop Dis       Date:  2012-11-08

10.  A history of chagas disease transmission, control, and re-emergence in peri-rural La Joya, Peru.

Authors:  Stephen Delgado; Ricardo Castillo Neyra; Víctor R Quispe Machaca; Jenny Ancca Juárez; Lily Chou Chu; Manuela Renee Verastegui; Giovanna M Moscoso Apaza; César D Bocángel; Aaron W Tustin; Charles R Sterling; Andrew C Comrie; César Náquira; Juan G Cornejo del Carpio; Robert H Gilman; Caryn Bern; Michael Z Levy
Journal:  PLoS Negl Trop Dis       Date:  2011-02-22
View more
  12 in total

Review 1.  Between a bug and a hard place: Trypanosoma cruzi genetic diversity and the clinical outcomes of Chagas disease.

Authors:  Louisa A Messenger; Michael A Miles; Caryn Bern
Journal:  Expert Rev Anti Infect Ther       Date:  2015-08       Impact factor: 5.091

2.  Use of a Latent Class Analysis in the Diagnosis of Chronic Chagas Disease in the Washington Metropolitan Area.

Authors:  Yagahira E Castro-Sesquen; Antonella Saldaña; Dhayanna Patino Nava; Tabitha Bayangos; Diana Paulette Evans; Kelly DeToy; Alexia Trevino; Rachel Marcus; Caryn Bern; Robert H Gilman; Kawsar R Talaat
Journal:  Clin Infect Dis       Date:  2021-05-04       Impact factor: 9.079

3.  Severity of Chagasic Cardiomyopathy Is Associated With Response to a Novel Rapid Diagnostic Test for Trypanosoma cruzi TcII/V/VI.

Authors:  Tapan Bhattacharyya; Louisa A Messenger; Caryn Bern; Pascal Mertens; Quentin Gilleman; Nicolas Zeippen; Bruno C Bremer Hinckel; Niamh Murphy; Robert H Gilman; Michael A Miles
Journal:  Clin Infect Dis       Date:  2018-08-01       Impact factor: 9.079

4.  Detection of anti-Trypanosoma cruzi antibodies by chimeric antigens in chronic Chagas disease-individuals from endemic South American countries.

Authors:  Rodrigo Pimenta Del-Rei; Leonardo Maia Leony; Paola Alejandra Fiorani Celedon; Nilson Ivo Tonin Zanchin; Mitermayer Galvão Dos Reis; Yara de Miranda Gomes; Alejandro Gabriel Schijman; Silvia Andrea Longhi; Fred Luciano Neves Santos
Journal:  PLoS One       Date:  2019-04-18       Impact factor: 3.240

5.  Development of a New Lateral Flow Assay Based on IBMP-8.1 and IBMP-8.4 Chimeric Antigens to Diagnose Chagas Disease.

Authors:  Edimilson D Silva; Ângelo A O Silva; Emily F Santos; Leonardo M Leony; Natália E M Freitas; Ramona T Daltro; Antônio G P Ferreira; Rafaela L Diniz; Aline R Bernardo; Alejandro O Luquetti; Marco A Krieger; Paola A F Celedon; Pedro A Viñas; Nilson I T Zanchin; Fred L N Santos
Journal:  Biomed Res Int       Date:  2020-08-17       Impact factor: 3.411

6.  Secretome analysis of Trypanosoma cruzi by proteomics studies.

Authors:  Jean-Yves Brossas; Julián Ernesto Nicolás Gulin; Margarita Maria Catalina Bisio; Manuel Chapelle; Carine Marinach-Patrice; Mallaury Bordessoules; George Palazon Ruiz; Jeremy Vion; Luc Paris; Jaime Altcheh; Dominique Mazier
Journal:  PLoS One       Date:  2017-10-03       Impact factor: 3.240

Review 7.  Treatment of Chagas Disease in the United States.

Authors:  Sheba Meymandi; Salvador Hernandez; Sandy Park; Daniel R Sanchez; Colin Forsyth
Journal:  Curr Treat Options Infect Dis       Date:  2018-06-26

8.  Highly Accurate Chimeric Proteins for the Serological Diagnosis of Chronic Chagas Disease: A Latent Class Analysis.

Authors:  Fred Luciano Neves Santos; Ana Clara Paixão Campos; Leila Denise Alves Ferreira Amorim; Edimilson Domingos Silva; Nilson Ivo Tonin Zanchin; Paola Alejandra Fiorani Celedon; Rodrigo Pimenta Del-Rei; Marco Aurélio Krieger; Yara Miranda Gomes
Journal:  Am J Trop Med Hyg       Date:  2018-11       Impact factor: 2.345

9.  A lineage-specific rapid diagnostic test (Chagas Sero K-SeT) identifies Brazilian Trypanosoma cruzi II/V/VI reservoir hosts among diverse mammalian orders.

Authors:  Mairi C W McClean; Tapan Bhattacharyya; Pascal Mertens; Niamh Murphy; Quentin Gilleman; Yves Gustin; Nicolas Zeippen; Samanta C C Xavier; Ana M Jansen; Michael A Miles
Journal:  PLoS One       Date:  2020-01-17       Impact factor: 3.240

10.  Glycosylation of Trypanosoma cruzi TcI antigen reveals recognition by chagasic sera.

Authors:  Niamh Murphy; Barrie Rooney; Tapan Bhattacharyya; Omar Triana-Chavez; Anja Krueger; Stuart M Haslam; Victoria O'Rourke; Magdalena Pańczuk; Jemima Tsang; Jack Bickford-Smith; Robert H Gilman; Kevin Tetteh; Chris Drakeley; C Mark Smales; Michael A Miles
Journal:  Sci Rep       Date:  2020-10-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.